Top

German health insurance regulator directs centres to report commercial CAR-T treatments to the EBMT Registry

The Gemeinsame Bundesausschuss (G-BA) published its directions on the treatment of German patients with CAR T-cell therapies.

Language:
English
Event year or document creation date

Download pdf

Press release_EBMT-G-BA_FINAL.pdf